SwedenLivingWorldBusinessSportsEntertainment

Novo Nordiskbörsen

Novo Nordisk stock falls just over 16% after phase 3 results trail Eli Lilly
Business News

Novo Nordisk stock falls just over 16% after phase 3 results trail Eli Lilly

Danish pharmaceutical giant Novo Nordisk has suffered another setback. The results of a phase 3 study were worse than those of competitor Eli Lilly, and its stock fell just over 16 percent
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald